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I examine whether short selling increases around reverse stock splits using 2019 daily short selling 
data instead of bimonthly short interest data required by FINRA. In my difference-in-difference 
analysis, I find that average short selling increases significantly for firms that reverse split their 
stock, relative to matched control firms that do not, around the split dates. I also find that firms 
that reverse split their stock experience negative cumulative abnormal returns in the 20-day period 
after the reverse stock splits, particularly for those firms that are heavily shorted. These results are 
in agreeance with existent literature and suggest that short sellers are informed and correctly 
predict future negative abnormal returns. The results also suggest that short sellers put downward 
pressure on stock prices after reverse splits.  
 











a Voges is a graduate student in the Master of Science in Financial Economics program in the Jon M. Huntsman School 






Under the assumption of efficient markets (Malkiel and Fama 1970; Fama, 1991), stock 
splits and reverse stock splits should have no fundamental effect on shareholder wealth. However, 
Fama, Fisher, Jensen, and Roll (1969) show that the prices for stocks that engage in splits change 
significantly both before and after the splits occur. Prior research suggests that reverse splits 
convey negative information to investors which results in negative post-split cumulative abnormal 
returns (Woolridge and Chambers, 1983; Desai and Jain, 1997). Given this information, investors 
might be inclined to take short positions on firms that perform a reverse stock split. Consistent 
with this notion, Diether, Lee, and Werner (2009) show that short sellers correctly predict future 
negative abnormal returns. Thus, it can be inferred that short sellers will be attracted to reverse 
stock splits.  
In this study, I seek to find the relation between a reverse split and the number of shares 
sold short. To the extent that stock prices drop on average around reverse stock splits, I expect to 
find an increase in abnormal short selling prior to the split. I also expect to find that short selling 
puts additional downward pressure on the prices of stocks that reverse split their shares. A common 
empirical measure of how many shares a particular stock is short is known as short interest, but 
the Financial Industry Regulatory Authority (FINRA) only requires firms to report short interest 
positions bi-monthly. This makes it difficult to know exactly when short sellers are taking their 
positions. It also makes it difficult to observe the magnitude of short positions taken on a particular 
stock day. To circumvent these concerns, I obtain daily short sale volumes by stock from 12 
different equity exchanges and from FINRA’s Trade Reporting Facility (TRF).1 This allows me to 
 
1 We are unable to obtain daily short sale volumes from the NASDAQ and IEX exchanges.  
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estimate daily short ratios, or the number of shares sold short to total shares outstanding, by stock 
day.    
The empirical results show that for firms that perform a reverse split, relative to a sample 
of matched control firms that do not, the average daily short ratio increases by 2.9 percentage 
points in the restricted model, and by 4.1 percentage points – other factors held constant. 
Furthermore, I find that for firms that perform a reverse split, relative to the sample of matched 
control firms that do not, the average cumulative abnormal return in the 20 trading days after the 
reverse split is negative 19.1%. When controlling for additional factors, this average cumulative 
abnormal return is negative 38.6%. Last, I find that short sellers put downward pressure on the 
prices of stocks that engage in reverse stock splits. In particular, the average 20-day cumulative 
abnormal return decreases significantly (between 0.84 and 1.012 percent depending on the model 
specification) with each unit increase in the daily short ratio.     
Combined my results of negative cumulative abnormal returns are consistent with previous 
research (see e.g., Lamoureax and Poon, 1987; Woolridge and Chambers, 1983). Perhaps more 
importantly, I find that the short ratio for firms that perform a reverse stock split increases 
significantly after the reverse split and that the worst performing stocks see the largest increase in 
short selling. These results seem to suggest that short sellers are not only informed and correctly 
predict future negative abnormal returns (Diether, Lee, and Werner, 2009), but they also place 
downward pressure on stocks that engage in reverse splits ex-post.  
2. Data Description 
2.1. Data Collection 
I gather daily short sale data from 12 different equity exchanges and the FINRA TRF. I 
gather additional daily pricing data from the Center for Research in Security Prices (CRSP) 
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database. From the CRSP database I collect exchange listing, daily prices, daily volume, daily 
shares outstanding, daily returns, daily ask high price, and daily bid low price for all stocks listed 
on an exchange in 2018 and 2019.  
[Insert Table 1 Here] 
I remove all observation that have missing daily share volume. I also ensure that all prices 
are positive. Next, I identify the date of the reverse stock split as the event date for each firm that 
performed a reverse stock split in 2019. At this point I have 196 firms that perform a reverse stock 
split in 2019 according to the CRSP database. I remove six firms from the sample that perform 
multiple reverse stock splits in 2019. I also exclude all 27 stocks with an event date in January or 
December to ensure there is sufficient data both before and after the split to yield accurate results. 
Next, I remove two firms that do not have positive short sale volume in the month prior to the 
reverse split. To create a benchmark for the treatment firms and to control for endogeneity, I match 
each firm that had a reverse stock split in 2019 to a control firm one-to-one without replacement. 
In the month prior to the reverse (pseudo-reverse) stock splits, I match firms on average market 
capitalization, price, and short ratio. The final sample consists of 161 unique firms that reverse 
split their stock during the sample period and 161 unique control firms that do not reverse split 
their stock during the same time period. This totals 322 firms in the final sample. 
2.2. Variable Descriptions 
In this subsection I describe the variables used in the empirical analysis. In Table 2, I report 
distributional characteristics, before the event dates (pseudo-event dates), for treatment stocks in 
Panel A, control stocks in Panel B, and the difference in means between the two in Panel C. The 
two outcome variables used in the empirical analysis are short ratio (SR) and cumulative abnormal 
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returns (CAR). The short ratio is defined as the number of shares sold short divided by the total 





  Price is the daily per share closing price of a stock. Volume is the total number of shares 
transacted daily for a given stock. Market capitalization (MCAP) is defined as price multiplied by 
shares outstanding. Return volatility (Rvolt) is the difference of the log of the daily high ask price 
and the log of the daily low bid price. % Spread is calculated as the difference between the daily 
closing ask and bid prices divided by the midpoint of the daily ask and bid prices. Illiquidity (Illiq) 
is Amihud’s (2002) illiquidity measure calculated as the absolute value of the daily return divided 
by daily dollar volume, scaled by 106. 
[Insert Table 2 Here] 
Panels A, B, and C from Table 2 show that the average SR for treatment stocks, control 
stocks and the difference between the two are 37.71%, 37.99%, and -0.29%, respectively. This 
shows that the SR difference between treatment stocks and control stocks is minimal prior to the 
event date. The average Price for treatment stocks is $2.4152 while control stocks have an average 
Price of $2.6380 with a difference between the two being -$0.2229. The average volume is 
2,676,314 and 596,615 for treatment stocks and control stocks, respectively, with a difference of 
2,079,699. The average MCAP for treatment stocks and control stocks is 673,207,788 and 
615,930,681, respectively, with a difference of 57,277,107. The average Rvolt is 9.68% and 7.77% 
for treatment stocks and control stocks, respectively, with a difference of 1.91%. The average % 
Spread is 1.64% and 1.85% for treatment stocks and control stocks, respectively, with a difference 
of -0.21%. The average Illiq is 0.6076 and 0.9945 for treatment stocks and control stocks, 
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respectively, with a difference of -0.3869. Panel C’s t-stat shows that only Volume, Rvolt, and Illiq 
are statistically different than zero at the 5% level.  
[Insert Table 3 Here] 
Table 3 shows the estimates of from a series of Pearson Correlation coefficients for all 
variables used in the analysis. The correlations of interest are between SR and all the independent 
variables (Price, Volume, MCAP, Rvolt, % Spread, and Illiq). The only variables that have a 
correlation coefficient statistically different than zero at the 1% level, when compared to SR, are 
Price, MCAP, and Rvolt. Price has a strong negative correlation of -0.2207 with SR. MCAP has a 
strong negative correlation of -0.1712 with SR. Rvolt has a strong positive correlation of 0.2592 
with SR. The correlation of Price and SR seems to suggest that stocks with a smaller per share 
price have a larger short ratio. Given that Price has a strong correlation with SR, I expect MCAP 
and Rvolt to have a similar correlation as MCAP and Rvolt are variables derived from Price. This 
is also shown in Table 3. Price has strong correlation with MCAP, Rvolt, and % Spread, all 
significant at the 1% level. 
3. Empirical Results 
3.1. Daily Short Ratio Analysis 
I begin my empirical analysis by running two univariate tests on the number of shares sold 
short, or the short ratio (SR). In these tests I look at the difference in means and the difference in 
medians for the pre and post periods for treatment and control stocks. 
[Insert Table 4 Here] 
Table 4, Panel A shows that treatment stocks, on average, have a 37.71% SR in the pre-period; but 
in the post period, the SR of treatment stocks increases to 42.15%. This is a significant increase of 
4.45 percentage points from the pre to post period. Additionally, the t-statistic for this difference 
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in means is 4.59, suggesting that the post to pre-period change is statistically significant at a 1% 
level. The control stocks, on average, have a 38.00% SR in the pre-period and in the post-period 
they have an average SR of 39.57%. This is an increase of 1.57 percentage points. While there is 
an increase in the SR for control stocks, the increase is not as drastic. The t-statistic for this pre to 
post period difference is 1.57, which is not statistically significant at the 10% level. Thus, it cannot 
be said that the difference in SR for control stocks from the pre to the post period is statistically 
different than zero. When looking at the difference between treatment and control stocks in the 
pre-period, Panel A shows there is a minimal difference in means. The difference between the two 
is -0.29% with a t-stat of -0.30. This t-stat suggests that the difference, in the pre-period, is not 
different than zero. However, in the post period, the difference in means for treatment and control 
stocks is 2.58 percentage points. This results in a t-stat of 2.55 which is statistically significant at 
the 5% level. Looking at the difference-in-difference of treatment and control stocks from the pre 
to the post period, there is an increase in the mean SR of 2.87 percentage points. The t-statistic is 
2.06 which is statistically significant at the 5% level. Therefore, it can be said that the difference-
in-difference is different than zero.  
 Table 4 Panel B shows the difference in medians, which shows similar results as Panel A. 
Panel B shows that the median of treatment stocks is 37.14% SR in the pre-period; but in the post 
period, the median SR for treatment stocks increases to 43.99%. This is a significant increase of 
6.85 percentage points from the pre to post period. Additionally, the P-value statistic for this 
difference in medians is 0.0001, suggesting that the post to pre-period change is statistically 
significant. The control stocks have a median of 38.69% SR in the pre-period and in the post period 
they have a median SR of 40.46%. This is an increase of 1.77 percentage points. The P-value for 
this pre to post period difference is 0.1208, which is not statistically significant. Thus, it cannot be 
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said that the difference in SR for the median control stocks from the pre to the post period is 
statistically different than zero. When looking at the difference between treatment and control 
stocks in the pre-period, Panel B shows there is a minimal difference in medians. The difference 
between the two is -1.55% with a p-value of 0.7739. This p-value suggests that the median 
difference, in the pre-period, is not different than zero. However, in the post period, the difference 
in medians for treatment and control stocks is 3.53 percentage points. This results in a p-value of 
0.0064 which is statistically significant. Looking at the difference-in-difference of treatment and 
control stocks from the pre to the post period, there is an increase in the median SR of 5.08 
percentage points. The p-value is 0.0090 which is statistically significant. Therefore, it can be said 
that the difference-in-difference is different than zero. These results are in support of my 
alternative hypothesis that treatment stocks that perform a reverse stock split see an increase in 
short selling after the reverse stock split. 
 After the univariate test, I ran a regression to further examine whether treatment stocks see 
an increase in short selling after the event date. To do this I estimate specifications of the following 
regression model: 
 
𝑆𝑅𝑖,𝑡 = 𝛽1𝑇𝑟𝑒𝑎𝑡𝑖 + 𝛽2𝑃𝑜𝑠𝑡𝑖,𝑡 + 𝛽3𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡 + 𝛽4𝑃𝑟𝑖𝑐𝑒𝑖,𝑡 + 𝛽5𝑀𝐶𝐴𝑃𝑖,𝑡
+ 𝛽6𝑅𝑣𝑜𝑙𝑡𝑖,𝑡 + 𝛽7% 𝑆𝑝𝑟𝑒𝑎𝑑𝑖,𝑡 + 𝛽8𝐼𝑙𝑙𝑖𝑞𝑖,𝑡 + 𝛼 + 𝜀𝑖,𝑡 
(1) 
  
where the dependent variable is 𝑆𝑅𝑖,𝑡, or the ratio of daily short selling volume to total volume for 
stock i on day t. The independent variables have been previously defined except for the interaction 
term 𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡. 𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡 indicates whether the stock is a treatment firm and 
whether the time window is before or after the event date. This interaction term allows me to 
specifically test if treatment firms see an increase in short selling after the event date. I report t-
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statistics in parentheses, obtained from robust standard errors clustering, below the reported beta 
coefficients for each of the independent variables and the interaction term. 
[Insert Table 5 Here] 
 In Table 5, column [1] is the restricted model, using only the independent variables Treat, 
and Post with the interaction term 𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡. When looking at the variable of interest, 
𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡, the results show that the average daily amount of short selling increases by 2.9 
percentage points for treatment firms relative to control firms after the reverse split. Column [2] 
shows the full regression model specification, controlling for another factor such as Price, MCAP, 
Rvolt, % Spread, and Illiq. The results of column [2] show that the variable of interest, 
𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡, results in an increase in daily short selling of 4.1 percentage points on average. 
[Insert Figure 1 Here] 
As a final verification, I plotted the average SR in the 20 days before and the 20 days after 
the event dates for 161 treatment firms and pseudo reverse stock splits for 161 matched control 
firms. The resulting graph suggests that, on average, there is an increase in the SR for treatment 
firms immediately after the event date and this increase in the SR is maintained throughout the 20-
day post period. Additionally, the average SR for control firms remains relatively constant 
throughout the entire sample period. The combined results of Table 4, Table 5, and Figure 1 
suggest that short selling increases immediately after a firm performs a reverse split. 
3.2. Cumulative Abnormal Returns Analysis 
 Table 6 reports the market reactions to the reverse stock splits for the 161 treatment firms 
and to the pseudo reverse stock splits for the 161 control firms. I estimate different models to 
capture the expected return of a stock after a reverse stock split. The first model is simple raw 
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returns. The second model is market adjusted returns. The market adjusted returns are calculated 
using the following abnormal return equation: 
 𝐴𝑅𝑖,𝑡 =  𝑅𝑖,𝑡 − 𝑅𝑚,𝑡 (2) 
where 𝑅𝑖,𝑡 is defined as the return of stock i at time period 𝑡 and 𝑅𝑚,𝑡 is the market return value-
weighted across CRSP securities on day t. The third model is the market model. These returns are 
calculated using the following equation: 
 𝐸[𝑅𝑖,𝑡] = 𝛽0 + 𝛽1𝑅𝑚,𝑡 (3) 
where the parameter estimates, 𝛽0 and 𝛽1, are estimated in the period ending 46 days before the 
event date with a maximum of 255 days and a minimum of 3 days. I then estimate the abnormal 
returns for each stock day during the event window using the following equation: 
 𝐴𝑅𝑖,𝑡 = 𝑅𝑖,𝑡 − 𝐸[𝑅𝑖,𝑡] (4) 
The fourth, and final model I use is the Fama-French-Carhart 4-Factor model. I obtain the 
parameter estimates from the following four-factor model that is estimated in the period ending 46 
days before the event date (maximum of 255 days and minimum of 3 days): 
 𝐸[𝑅𝑖,𝑡] = 𝛽0 + 𝛽1𝐸𝑋𝑀𝐾𝑇𝑡 + 𝛽2𝐻𝑀𝐿𝑡 + 𝛽3𝑆𝑀𝐵𝑡 + 𝛽4𝑈𝑀𝐷𝑡 (5) 
where 𝐸𝑋𝑀𝐾𝑇𝑡 is the market risk premium, the return on the market value weighted across CRSP 
securities on day t minus the risk-free return. 𝐻𝑀𝐿𝑡 is the high minus low book-to-market risk 
factor. SMB is the small minus large market capitalization risk factor. UMD is the up-minus-down 
momentum risk factor. The first two risk factors are discussed in Fama and French (1993), while 
the last is outlined in Carhart (1997). I then estimate the abnormal returns for each stock day during 
the event window using equation (4).  
The cumulative abnormal returns for each model are estimated as the sum of the abnormal 









 [Insert Table 6 Here] 
 Table 6 Panel A shows the raw returns for treatment stocks, control stocks, and the 
difference between the two. On average, treatment stocks have returns of -4.15%, -5.46%, -7.81% 
and -11.66% for 1 day, 3 days, 5 days, and 20 days, respectively, following the reverse stock split. 
Control stocks, on average, have returns of 1.63%, 2.66%, 3.35% and 10.07% for 1 day, 3 days, 5 
days, and 20 days, respectively, following the reverse stock split. On average, the difference in 
returns between treatment and control stocks is -5.78%, -8.12%, -11.16% and -21.73% for 1 day, 
3 days, 5 days, and 20 days, respectively, following the reverse stock split. 
 Panel B reports the market adjusted returns for treatment stocks, control stocks, and the 
difference between the two. On average, treatment stocks have market adjusted returns of -4.42%, 
-5.80%, -8.25% and -13.19% for 1 day, 3 days, 5 days, and 20 days, respectively, following the 
reverse stock split. Control stocks, on average, have market adjusted returns of 1.36%, 2.31%, 
2.91% and 8.53% for 1 day, 3 days, 5 days, and 20 days, respectively, following the reverse stock 
split. On average, the difference in market adjusted returns between treatment and control stocks 
is -5.78%, -8.11%, -11.16% and -21.72% for 1 day, 3 days, 5 days, and 20 days, respectively, 
following the reverse stock split. 
 Panel C reports the market model returns for treatment stocks, control stocks, and the 
difference between the two. On average, treatment stocks have a market model return of -3.81%, 
-4.60%, -6.77% and -6.92% for 1 day, 3 days, 5 days, and 20 days, respectively, following the 
reverse stock split. Control stocks, on average, have a market model return of 1.71%, 2.83%, 
3.77% and 12.17% for 1 day, 3 days, 5 days, and 20 days, respectively, following the reverse stock 
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split. On average, the difference in the market model returns between treatment and control stocks 
is -5.52%, -7.43%, -10.54% and -19.09% for 1 day, 3 days, 5 days, and 20 days, respectively, 
following the reverse stock split. 
 Panel D reports the returns using the Fama-French 4-Factor alphas model for treatment 
stocks, control stocks, and the difference between the two. On average, treatment stocks have 
returns of -3.66%, -4.36%, -6.58% and -6.08% for 1 day, 3 days, 5 days, and 20 days, respectively, 
following the reverse stock split. Control stocks, on average, have returns of 1.84%, 3.06%, 3.66% 
and 12.01% for 1 day, 3 days, 5 days, and 20 days, respectively, following the reverse stock split. 
On average, the difference in returns between treatment and control stocks is -5.50%, -7.42%, -
10.24% and -18.09% for 1 day, 3 days, 5 days, and 20 days, respectively, following the reverse 
stock split. 
 Together, the results from Table 6 are consistent with previous research Woolridge and 
Chambers, 1983; Desai and Jain, 1997) and suggest that firms that perform a reverse stock split 
have negative returns in the 20 days following the reverse stock split. Additionally, these results 
validate the findings from Tables 4 and 5, and from Figure 1. 
3.3. Cross-Sectional Regressions Analysis 
 In this final subsection, I estimate four different cross-sectional regressions on the dataset 
to see the effect of treatment stocks and short selling on returns. Table 7 shows the results of these 
regressions. More specifically, I estimate specifications of the following regression model: 
 
𝐶𝐴𝑅𝑖 = 𝛽1𝑇𝑟𝑒𝑎𝑡𝑖 + 𝛽2𝑆𝑅𝑖 + 𝛽3𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑆𝑅𝑖 + 𝛽4𝑃𝑟𝑖𝑐𝑒𝑖 + 𝛽5𝑀𝐶𝐴𝑃𝑖 + 𝛽6𝑅𝑣𝑜𝑙𝑡𝑖
+ 𝛽7% 𝑆𝑝𝑟𝑒𝑎𝑑𝑖 + 𝛽8𝐼𝑙𝑙𝑖𝑞𝑖 + 𝛼 + 𝜀𝑖 
(8) 
where the dependent variable is the value-weighted market model cumulative abnormal returns in 
the 20 days following the reverse stock splits for 161 treatment firms and the pseudo reverse stock 
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splits for the 161 matched control firms. The variable 𝑇𝑟𝑒𝑎𝑡𝑖 is the variable of interest in 
regressions [1] and [2]. While the interaction term 𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑆𝑅𝑖 is the variable of interest in 
regressions [3] and [4]. All the independent variables have been previously defined. 
[Insert Table 7 Here] 
Table 7, column [1] is the most restrictive model using only the independent variable 𝑇𝑟𝑒𝑎𝑡. The 
coefficient of 𝑇𝑟𝑒𝑎𝑡 is -0.191 and significant suggesting that stocks that have a reverse split, on 
average, see negative abnormal returns of -19.1% in the 20 trading days following the reverse 
stock split. Column [2] controls for more factors, such as 𝑃𝑟𝑖𝑐𝑒, 𝑀𝐶𝐴𝑃,  𝑅𝑣𝑜𝑙𝑡, % 𝑆𝑝𝑟𝑒𝑎𝑑, and 
𝐼𝑙𝑙𝑖𝑞. The regression estimates the coefficient of 𝑇𝑟𝑒𝑎𝑡 as -0.386 and significant. This suggests 
that stocks that have a reverse stock split, on average, see negative abnormal returns of -38.6% in 
the 20 trading days following the reverse stock split. Column [3] is another restrictive model using 
the independent variables 𝑇𝑟𝑒𝑎𝑡, 𝑆𝑅, and  𝑇𝑟𝑒𝑎𝑡 𝑥 𝑆𝑅. The variable of interest, 𝑇𝑟𝑒𝑎𝑡 𝑥 𝑆𝑅, has 
a coefficient of -1.012 and is significant, suggesting that treatment firms, on average, see a decrease 
in returns of 101.2 basis points for every 1 percentage point increase in the short ratio. Column [4] 
is the full regression model. The coefficient of the interaction term 𝑇𝑟𝑒𝑎𝑡 𝑥 𝑆𝑅 is -0.841 and is 
significant, suggesting that treatment firms, on average, see a decrease in returns of 84.1 basis 
points for every 1 percentage point increase in the short ratio. All four regression models from 
Table 7 suggest the same thing, stocks that have a reverse stock split significantly underperform 
the market in the 20 days following the reverse stock split.  
4. Conclusion 
In this study, I develop the hypotheses that short selling increases around reverse stock 
splits, and that short selling puts additional downward pressure on the prices of stocks that reverse 
split their shares. Diether, Lee, and Werner (2009) show that short sellers correctly predict future 
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negative abnormal returns generating significant positive returns. Woolridge and Chambers (1983) 
and Lamoureax and Poon (1987) show that reverse splits result in significantly negative stock 
returns. From these findings, it can reasonably be inferred that short sellers will be attracted to 
reverse splits.  
 To control for endogeneity and to create a benchmark for the firms that perform a reverse 
split, I match each firm that had a reverse split in 2019 to a control firm one-to-one, without 
replacement based on market capitalization, price, and short ratio. I find that the average short ratio 
significantly increases for firms that reverse split their stock, relative to matched control firms that 
do not, other factors held constant. In economic terms, stocks that perform a reverse split see an 
average increase in short ratio between 2.9% and 4.1%, other factors held constant. I also estimate 
cumulative abnormal returns in various event windows after the reverse splits and pseudo reverse 
splits. I find that the average CARs for stocks that perform a reverse split are negative and 
significant, while those for control firms are generally positive or insignificant. These findings are 
consistent with Woolridge and Chambers (1983) and Lamoureax and Poon (1987). More 
importantly, I find that short selling puts additional downward pressure on the prices of stocks that 
reverse split their shares.  
 I believe this research is of particular importance for short sellers and for firms that are 
considering a reverse stock split. It appears that short sellers can capture profits from a trading 
strategy of selling short stocks that perform a reverse split. These results also suggest that short 
sellers are informed and correctly predict future negative abnormal returns. For firms 
contemplating a reverse stock split, they should be aware that short sellers will likely place 
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Table 1. Sample Filters 
This table reports the filters used to arrive at the final sample. The data are obtained from the Center for Research 
in Security Prices (CRSP) database for all trading days in 2019.  
Filter # of Stocks 
Reverse stock splits in 2019 according to the CRSP database 196 
Exclude stocks with more than one reverse stock split in 2019 6 
Exclude January and December reverse stock splits in 2019 27 
Exclude stocks without positive short sale volume in month prior to reverse stock split 2 
Control firms that did not have a reverse stock split in 2019 161 






Table 2. Summary Statistics 
This table reports summary statistics that describe the sample. The following statistics are produced using stock-
day observations in the 20 days before the reverse stocks splits for the 161 treatment firms (Panel A) and the 20 
days before the pseudo reverse stock splits for the 161 matched control firms (Panel B). SR is the ratio of daily short 
volume to total volume. Price is the daily closing price. Volume is the daily share volume. MCAP is the daily market 
capitalization, which is the daily closing price times shares outstanding. Rvolt is the daily range-based volatility, or 
the natural log of the daily high ask price minus the natural log of the daily low bid price. % Spread is the daily 
closing spread, or the difference between the closing ask and bid prices, scaled by the closing quote midpoint. Illiq 
is the daily absolute return divided by dollar volume.  
Panel A. Treatment Stocks 
  Mean Std. Dev. p25 Median p75 
SR 0.3771 0.0841 0.3260 0.3714 0.4443 
Price 2.4152 6.2718 0.3101 0.4980 1.0881 
Volume 2,676,314 5,562,480 206,450 653,269 2,057,840 
MCAP 673,207,788 5,637,486,159 7,274,506 16,292,320 55,297,357 
Rvolt 0.0968 0.0530 0.0703 0.0894 0.1238 
% Spread 0.0164 0.0126 0.0060 0.0139 0.0228 
Illiq 0.6076 1.1609 0.0528 0.1810 0.6544 
      
Panel B. Control Stocks 
  Mean Std. Dev. p25 Median p75 
SR 0.3799 0.0882 0.3094 0.3868 0.4452 
Price 2.6380 6.2278 0.5189 0.7921 1.3591 
Volume 596,615 1,211,325 60,873 192,037 422,782 
MCAP 615,930,681 4,979,064,965 9,721,896 14,618,074 60,711,251 
Rvolt 0.0777 0.0409 0.0503 0.0725 0.1008 
% Spread 0.0185 0.0131 0.0093 0.0158 0.0257 
Illiq 0.9945 1.9067 0.0907 0.3649 1.0504 
      
Panel C. Difference in Means (Treatment - Control) 
  Difference t-stat       
SR -0.0029 -0.30    
Price -0.2229 -0.32    
Volume 2,079,699 4.64    
MCAP 57,277,107 0.10    
Rvolt 0.0191 3.63    
% Spread -0.0021 -1.47    






Table 3. Correlation Matrix 
This table reports pooled correlation coefficients for the variables used throughout the analysis. The correlations 
are produced using stock-day observations in the 20 days before the reverse stocks splits for the 161 treatment firms 
and the 20 days before the pseudo reverse stock splits for the 161 matched control firms. SR is the ratio of daily 
short volume to total volume. Price is the daily closing price. Volume is the daily share volume. MCAP is the daily 
market capitalization, which is the daily closing price times shares outstanding. Rvolt is the daily range-based 
volatility, or the natural log of the daily high ask price minus the natural log of the daily low bid price. % Spread is 
the daily closing spread, or the difference between the closing ask and bid prices, scaled by the closing quote 
midpoint. Illiq is the daily absolute return divided by dollar volume. P-values are reported in brackets.   
  SR Price Volume MCAP Rvolt % Spread Illiq 
SR 1       
        
Price -0.2207 1      
 <.0001       
Volume 0.1212 0.1472 1     
 0.0297 0.0081      
MCAP -0.1712 0.4916 0.1959 1    
 0.0021 <.0001 0.0004     
Rvolt 0.2592 -0.3884 0.1032 -0.1631 1   
 <.0001 <.0001 0.0644 0.0033    
% Spread 0.0325 -0.3481 -0.2998 -0.1537 0.3448 1  
 0.5614 <.0001 <.0001 0.0057 <.0001   
Illiq -0.1067 -0.1347 -0.1758 -0.0598 0.0249 0.7034 1 






Table 4. Short Selling around Reverse Stock Splits – Univariate  
This table reports the results from univariate tests on short selling around reverse stock splits. The means and 
medians are produced using stock-day observations in the 20 days before and after the reverse stocks splits for the 
161 treatment firms and the 20 days before and after the pseudo reverse stock splits for the 161 matched control 
firms. SR is the ratio of daily short volume to total volume. T-statistics are reported in parentheses, while p-values 
are reported in brackets.   
Panel A. Difference in Means 
  Treatment Control Diff (Treatment - Control) t-stat 
Pre 37.71% 38.00% -0.29% -0.30 
Post 42.15% 39.57% 2.58%*** 2.55 
Diff (Post - Pre) 4.45%*** 1.57% 2.87%** 2.06 
t-stat 4.59 1.57     
Panel B. Difference in Medians 
  Treatment Control Diff (Treatment - Control) p-value 
Pre 37.14% 38.69% -1.55% 0.7739 
Post 43.99% 40.46% 3.53%*** 0.0064 
Diff (Post - Pre) 6.85%*** 1.77% 5.08%*** 0.0090 






Table 5. Short Selling around Reverse Stock Splits – Simple Regressions  
This table reports the results from estimating the following regression equation on stock-day observations in the 20 
days before and after reverse stock splits for 161 treatment firms and pseudo reverse stock splits for 161 matched 
control firms.  
𝑆𝑅𝑖,𝑡 = 𝛽1𝑇𝑟𝑒𝑎𝑡𝑖 + 𝛽2𝑃𝑜𝑠𝑡𝑖,𝑡 + 𝛽3𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑃𝑜𝑠𝑡𝑖,𝑡 + 𝛽4𝑃𝑟𝑖𝑐𝑒𝑖,𝑡 + 𝛽5𝑀𝐶𝐴𝑃𝑖,𝑡 + 𝛽6𝑅𝑣𝑜𝑙𝑡𝑖,𝑡 + 𝛽7% 𝑆𝑝𝑟𝑒𝑎𝑑𝑖,𝑡
+ 𝛽8𝐼𝑙𝑙𝑖𝑞𝑖,𝑡 + 𝛼 + 𝜀𝑖,𝑡 
where the dependent variable, SR, is the ratio of daily short selling volume to total volume. Treat is an indicator 
variable equal to one if the stock had a reverse split during 2019 and zero if the stock is a matched control firm. 
Post is a dummy variable equal to one if the treatment (control) firm observation is during the 20 days after the 
reverse stock split (pseudo reverse stock split) and zero otherwise. Price is the daily closing price. Volume is the 
daily share volume. MCAP is the daily market capitalization, which is the daily closing price times shares 
outstanding. Rvolt is the daily range-based volatility, or the natural log of the daily high ask price minus the natural 
log of the daily low bid price. % Spread is the daily closing spread, or the difference between the closing ask and 
bid prices, scaled by the closing quote midpoint. Illiq is the daily absolute return divided by dollar volume. T-
statistics are in parentheses obtained from robust standard errors clustering at the stock level. ***, *, * denote 
statistical significance at the 0.01, 0.05, and 0.10 levels, respectively.    
  [1] [2] 
Treat -0.003 -0.007 
 (-0.321) (-0.767) 
Post 0.015** 0.015** 
 (2.539) (2.476) 
Treat x Post 0.029*** 0.041*** 
 (3.338) (4.232) 
Price  -0.002*** 
  (-2.970) 
MCAP (in $billions)  -0.002*** 
  (-3.791) 
Rvolt  0.142** 
  (2.567) 
% Spread  -0.204 
  (-1.407) 
Illiq  -0.001** 
  (-2.093) 
Constant 0.380*** 0.381*** 
 (55.028) (44.810) 
 
  
Adj. R2  0.011 0.041 






Table 6. CARs around Reverse Stock Splits  
This table reports returns following the reverse stock splits for the 161 treatment firms and the pseudo reverse stock 
splits for the 161 matched control firms. The abnormal returns are cumulated over various event windows.  
Panel A. Raw Returns 
Event Window Treatment Control Diff (Treatment - Control) 
[0, +1] -4.15% 1.63% -5.78%*** 
[0, +3] -5.46% 2.66% -8.12%*** 
[0, +5] -7.81% 3.35% -11.16%*** 
[0, +20] -11.66% 10.07% -21.73%*** 
Panel B. Market Adjusted Returns 
Event Window Treatment Control Diff (Treatment - Control) 
[0, +1] -4.42% 1.36% -5.78%*** 
[0, +3] -5.80% 2.31% -8.11%*** 
[0, +5] -8.25% 2.91% -11.16%*** 
[0, +20] -13.19% 8.53% -21.72%*** 
Panel C. Market Model Returns 
Event Window Treatment Control Diff (Treatment - Control) 
[0, +1] -3.81% 1.71% -5.52%*** 
[0, +3] -4.60% 2.83% -7.43%*** 
[0, +5] -6.77% 3.77% -10.54%*** 
[0, +20] -6.92% 12.17% -19.09%*** 
Panel D. FF4-Factor Alphas 
Event Window Treatment Control Diff (Treatment - Control) 
[0, +1] -3.66% 1.84% -5.50%*** 
[0, +3] -4.36% 3.06% -7.42%*** 
[0, +5] -6.58% 3.66% -10.24%*** 





Table 7. CARs around Reverse Stock Splits – Cross-Sectional Regressions  
This table reports the results from estimating specifications of the following cross-sectional regression equation: 
𝐶𝐴𝑅𝑖 = 𝛽1𝑇𝑟𝑒𝑎𝑡𝑖 + 𝛽2𝑆𝑅𝑖 + 𝛽3𝑇𝑟𝑒𝑎𝑡𝑖 × 𝑆𝑅𝑖 + 𝛽4𝑃𝑟𝑖𝑐𝑒𝑖 + 𝛽5𝑀𝐶𝐴𝑃𝑖 + 𝛽6𝑅𝑣𝑜𝑙𝑡𝑖 + 𝛽7% 𝑆𝑝𝑟𝑒𝑎𝑑𝑖 + 𝛽8𝐼𝑙𝑙𝑖𝑞𝑖
+ 𝛼 + 𝜀𝑖 
where the dependent variable is the value-weighted market model cumulative abnormal returns in the 20 days 
following the reverse stock splits for the 161 treatment firms and the pseudo reverse stock splits for the 161 matched 
control firms. Treat is an indicator variable equal to one if the stock had a reverse split during 2019 and zero if the 
stock is a matched control firm. SR is the ratio of daily short selling volume to total volume. The following variables 
are averaged over the 20-day post-event sample period by stock. Price is the average daily closing price. Volume 
is the average daily share volume. MCAP is the average daily market capitalization, which is the daily closing price 
times shares outstanding. Rvolt is the average daily range-based volatility, or the natural log of the daily high ask 
price minus the natural log of the daily low bid price. % Spread is the average daily closing spread, or the difference 
between the closing ask and bid prices, scaled by the closing quote midpoint. Illiq is the average daily absolute 
return divided by dollar volume. T-statistics are reported in parentheses obtained from robust standard errors. ***, 
*, * denote statistical significance at the 0.01, 0.05, and 0.10 levels, respectively.   
  [1] [2] [3] [4] 
Treat -0.191*** -0.386*** 0.213 -0.034 
 (-3.610) (-5.604) (1.181) (-0.169) 
SR   0.873*** 0.194 
   (2.878) (0.652) 
Treat x SR   -1.012** -0.841* 
   (-2.037) (-1.689) 
Price  0.010***  0.009*** 
  (4.223)  (4.010) 
MCAP (in $billions)  -0.007**  -0.007* 
  (-2.510)  (-1.940) 
Rvolt  3.483***  3.622*** 
  (3.436)  (3.422) 
% Spread  -1.025  -1.096 
  (-0.472)  (-0.505) 
Illiq  -0.001  -0.000 
  (-0.111)  (-0.003) 
Constant 0.122*** -0.170** -0.224** -0.256** 
 (3.360) (-2.248) (-2.216) (-2.432) 
     
Adj. R2 0.036 0.133 0.044 0.135 






Figure 1. Short Selling around Reverse Stock Splits 
This figure displays average SR in the 20 days before and after reverse stock splits for 161 treatment firms and 
pseudo reverse stock splits for 161 matched control firms. SR is the ratio of daily short selling volume to total 
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